Asset Allocation

As of November 30, 2025.
Type % Net
Cash 46.69%
Stock 18.79%
Bond 34.11%
Convertible 0.00%
Preferred 0.00%
Other 0.41%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 55.74%    % Emerging Markets: 1.05%    % Unidentified Markets: 43.21%

Americas 54.71%
54.35%
Canada 3.77%
United States 50.58%
0.36%
Mexico 0.25%
Peru 0.07%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.01%
United Kingdom 0.20%
0.34%
Ireland 0.23%
Netherlands 0.02%
Switzerland 0.09%
0.00%
0.47%
South Africa 0.47%
Greater Asia 1.06%
Japan 0.00%
0.77%
Australia 0.77%
0.03%
Singapore 0.03%
0.26%
China 0.09%
Indonesia 0.16%
Unidentified Region 43.21%

Bond Credit Quality Exposure

AAA 0.00%
AA 72.63%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 27.37%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
11.75%
Materials
8.04%
Consumer Discretionary
1.23%
Financials
1.78%
Real Estate
0.70%
Sensitive
4.71%
Communication Services
0.48%
Energy
0.55%
Industrials
1.83%
Information Technology
1.85%
Defensive
3.21%
Consumer Staples
0.81%
Health Care
1.61%
Utilities
0.79%
Not Classified
80.32%
Non Classified Equity
0.02%
Not Classified - Non Equity
80.31%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 100.00%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
76.46%
Less than 1 Year
76.46%
Intermediate
23.54%
1 to 3 Years
23.54%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial